Sorrell, MF, et al.
National Institutes of Health Consensus Development Conference Statement: management of hepatitis B. Annals of Internal Medicine
2009; 150: 104–110.
Lavanchy, D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of Viral Hepatology
2004; 11: 97–107.
Papatheodoridis, G, et al.
EASL Clinical Practice Guidelines: management of chronic hepatitis B virus infection. Journal of Hepatology
2012; 57: 167–185.
Villa, E, et al.
Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis. Digestive and Liver Disease
2011; 43S: S8–S14.
McMahan, BJ, et al.
Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Annals of Internal Medicine
2001; 135: 759–768.
Kim, JH, et al.
Factors associated with natural seroclearance of hepatitis B surface antigen and prognosis after seroclearance: a prospective follow-up study. Hepatogastroenterology
2008; 55: 578–581.
Simonetti, J, et al.
Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus. Hepatology
2010; 51: 1531–1537.
Arase, Y, et al.
Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B. American Journal of Medicine
2006; 119: e9–16.
Ahn, SH, et al.
Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. Journal of Hepatology
2005; 42: 188–194.
Chen, YC, et al.
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology
2002; 123: 1084–1089.
Chu, CM, Liaw, YF. HBsAg seroclearance in asymptomatic carriers of high endemic area: appreciably high rates during a long term follow up. Hepatology
2007; 45: 1187–1192.
Liaw, YF, et al.
Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection:a prospective study. Hepatology
1991; 13: 627–631.
Thio, CL, Hawkins, C. Hepatitis B virus and hepatitis delta virus. In: Bennett, JE, Dolin, R, Blaser, MJ, eds. In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease, 18th edn.
Canada: Elsevier Saunders, 2015, pp. 1815–1839.
Fattovich, G, et al.
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. American Journal of Gastroenterology
1998; 93: 896–900.
Yuen, MF, et al.
HBsAg seroclearance in chronic hepatitis B in the Chinese: virology, histological and clinical aspects. Hepatology
2004; 39: 1694–1701.
Huo, TI, et al.
Seroclearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology
1999; 28: 231–236.
Draelos, M, et al.
Significance of isolated antibody to hepatitis B core antigen determined by immune response to hepatitis B vaccination. Journal of the American Medical Association
1987; 258: 1193–1195.
Manno, M, et al.
Natural history of chronic HBV carriers in Northern Italy: morbidity and mortality after 30 years. Gastroenterology
2004; 127: 756–763.
Chen, YC, et al.
Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infection. Clinical Gastroenterology and Hepatology
2012; 10: 297–302.
Kim, GA, et al.
Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance. Journal of Hepatology
2014; 62: 1092–1099.
Yuen, MF, et al.
HBsAg seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology
2008; 135: 1192–1199.
Ferreira, SC, et al.
Factors associated with spontaneous HBsAg clearance in chronic hepatitis B patients followed at a university hospital. Annals of Hepatology
2014; 13: 762–770.
Liu, J, et al.
Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma. Gut
2014; 63: 1648–57.
Adachi, H, et al.
Clearance of HBsAg in seven patients with chronic hepatitis B. Hepatology
1992; 16: 1334–1337.